Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features-Reference-Cited by-同舟云学术

Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features

Published:2023-04-23 Issue:5 Volume:23 Page:445-456
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Chen Yi¹^ORCID,Liu Xiaoling¹,Huang Liyun¹,Chen Lihong¹²³,Wang Bin¹²³^ORCID

Affiliation:

1. Department of Pathology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China

2. Department of Pathology and Institute of Oncology, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China

3. Diagnostic Pathology Center, Fujian Medical University, Fuzhou, Fujian, China

Funder

Fuzhou health technology project

high-level hospital foster grants from Fujian Provincial Hospital, Fujian province, China

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737159.2023.2205588

Reference33 articles.

1. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

2. Current omics-based biomarkers for cholangiocarcinoma

3. Cholangiocarcinoma — evolving concepts and therapeutic strategies

4. Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis

5. Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrahepatic cholangiocarcinoma with FGFR2 fusion gene positive that responded to pemigatinib and caused hypophosphatemia;International Cancer Conference Journal;2023-07-03